Page last updated: 2024-10-30

mesalamine and Stomatitis, Aphthous

mesalamine has been researched along with Stomatitis, Aphthous in 1 studies

Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.

Stomatitis, Aphthous: A recurrent disease of the oral mucosa of unknown etiology. It is characterized by small white ulcerative lesions, single or multiple, round or oval. Two to eight crops of lesions occur per year, lasting for 7 to 14 days and then heal without scarring. (From Jablonski's Dictionary of Dentistry, 1992, p742)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Collier, PM1
Neill, SM1
Copeman, PW1

Trials

1 trial available for mesalamine and Stomatitis, Aphthous

ArticleYear
Topical 5-aminosalicylic acid: a treatment for aphthous ulcers.
    The British journal of dermatology, 1992, Volume: 126, Issue:2

    Topics: Administration, Topical; Adult; Aged; Aminosalicylic Acids; Double-Blind Method; Female; Humans; Mal

1992